Literature DB >> 28177757

MicroRNA-181 inhibits proliferation and promotes apoptosis of chondrocytes in osteoarthritis by targeting PTEN.

Xiao-Feng Wu1, Zi-Hui Zhou2, Jian Zou2.   

Abstract

OBJECTIVE: To investigate the effects of microRNA-181 (miR-181) on the proliferation and apoptosis of chondrocytes in osteoarthritis (OA) by targeting PTEN.
METHODS: The chondrocytes in logarithmic growth phase were selected and divided into 6 test groups: the normal, blank, negative control, miR-181 mimic, miR-181 inhibitor, and miR-181 inhibitor + PTEN-siRNA groups. Reverse transcription qPCR was used to detect the expressions of miR-181 and PTEN mRNA. MTT assay and flow cytometry were performed to detect cell proliferation and apoptosis. The protein expressions of PARP and caspase-3 and the activity of MMP-2 and MMP-9 were detected by Western blotting and gelatin zymography assay.
RESULTS: The miR-181 mimic group showed increased miR-181 expression and decreased PTEN expression compared with the other 5 groups. Also, by comparison with the other 5 groups, the cell proliferation rate declined and the rate of cell apoptosis was elevated in the miR-181 mimic group. The MiR-181 mimic group showed remarkably increased protein expression of caspase-3 and PARP compared with the other 5 groups. The activity of MMP-2 and MMP-9 was higher in the miR-181 mimic group than the other 5 groups.
CONCLUSION: MiR-181 could up-regulate the expressions of caspase-3, PARP, MMP-2, and MMP-9, and thereby inhibit cell proliferation and promote apoptosis of chondrocytes in OA by targeting PTEN.

Entities:  

Keywords:  PTEN; apoptose; apoptosis; chondrocytes; microARN-181; microRNA-181; osteoarthritis; ostéoarthrite; proliferation; prolifération

Mesh:

Substances:

Year:  2017        PMID: 28177757     DOI: 10.1139/bcb-2016-0078

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  25 in total

1.  MicroRNA-181 inhibits the proliferation, drug sensitivity and invasion of human glioma cells by targeting Selenoprotein K (SELK).

Authors:  Chun-Hua Xu; Li-Min Xiao; Er-Ming Zeng; Li-Ke Chen; Su-Yue Zheng; Dong-Hai Li; Yue Liu
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

Review 2.  MicroRNAs in orthopaedic research: Disease associations, potential therapeutic applications, and perspectives.

Authors:  Audrey McAlinden; Gun-Il Im
Journal:  J Orthop Res       Date:  2017-12-19       Impact factor: 3.494

3.  The molecular mechanism of treating osteoarthritis with dipsacus saponins by inhibiting chondrocyte apoptosis.

Authors:  Xian-Rang Li; Jian Li; Qiang Ren; Shui Sun
Journal:  Exp Ther Med       Date:  2017-08-30       Impact factor: 2.447

Review 4.  The complex landscape of microRNAs in articular cartilage: biology, pathology, and therapeutic targets.

Authors:  Helal Endisha; Jason Rockel; Igor Jurisica; Mohit Kapoor
Journal:  JCI Insight       Date:  2018-09-06

5.  MicroRNA-181a/b-1 over-expression enhances osteogenesis by modulating PTEN/PI3K/AKT signaling and mitochondrial metabolism.

Authors:  Hongjun Zheng; Jin Liu; Eric Tycksen; Ryan Nunley; Audrey McAlinden
Journal:  Bone       Date:  2019-03-19       Impact factor: 4.626

6.  Ten Hotspot MicroRNAs and Their Potential Targets of Chondrocytes Were Revealed in Osteoarthritis Based on Bibliometric Analysis.

Authors:  Wei-Shang Hu; Qi Zhang; Si-Hui Li; Shuang-Chun Ai; Qiao-Feng Wu
Journal:  J Healthc Eng       Date:  2022-04-09       Impact factor: 3.822

7.  Molecular mechanism of miR-181b in heart disease due to pregnancy-induced hypertension syndrome.

Authors:  Zheng Gao; Li Wang; Jinyun Wang; Fengyong Yang; Jin Qu
Journal:  Exp Ther Med       Date:  2017-08-03       Impact factor: 2.447

8.  miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.

Authors:  Jiangang Liu; Yingru Xing; Ling Rong
Journal:  Oncol Rep       Date:  2018-02-13       Impact factor: 3.906

9.  MicroRNA Profiling in Cartilage Ageing.

Authors:  Panagiotis Balaskas; Katarzyna Goljanek-Whysall; Peter Clegg; Yongxiang Fang; Andy Cremers; Pieter Emans; Tim Welting; Mandy Peffers
Journal:  Int J Genomics       Date:  2017-08-14       Impact factor: 2.326

10.  Elevated KLF7 levels may serve as a prognostic signature and might contribute to progression of squamous carcinoma.

Authors:  Jingrun Yang; Kuixia Xie; Zihui Wang; Chengxin Li
Journal:  FEBS Open Bio       Date:  2020-07-13       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.